These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 34965407)
1. CYP 450 enzymes influence (R,S)-ketamine brain delivery and its antidepressant activity. Nguyen TML; McGowan JC; Gardier AM Neuropharmacology; 2022 Mar; 206():108936. PubMed ID: 34965407 [TBL] [Abstract][Full Text] [Related]
2. (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice. Yamaguchi JI; Toki H; Qu Y; Yang C; Koike H; Hashimoto K; Mizuno-Yasuhira A; Chaki S Neuropsychopharmacology; 2018 Aug; 43(9):1900-1907. PubMed ID: 29802366 [TBL] [Abstract][Full Text] [Related]
12. Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine. Shirayama Y; Hashimoto K Int J Neuropsychopharmacol; 2018 Jan; 21(1):84-88. PubMed ID: 29155993 [TBL] [Abstract][Full Text] [Related]
13. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression. Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360 [TBL] [Abstract][Full Text] [Related]
14. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184 [TBL] [Abstract][Full Text] [Related]
15. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model. Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218 [TBL] [Abstract][Full Text] [Related]
16. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Hashimoto K Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Hashimoto K Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141 [TBL] [Abstract][Full Text] [Related]
18. Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice. Yamagishi A; Ikekubo Y; Mishina M; Ikeda K; Ide S J Pharmacol Sci; 2024 Mar; 154(3):203-208. PubMed ID: 38395521 [TBL] [Abstract][Full Text] [Related]
19. cAMP-dependent protein kinase signaling is required for ( Riggs LM; Pereira EFR; Thompson SM; Gould TD J Neurophysiol; 2024 Jan; 131(1):64-74. PubMed ID: 38050689 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of ketamine action as an antidepressant. Zanos P; Gould TD Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]